{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:32:51Z","timestamp":1780633971902,"version":"3.54.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1F1A1049320"],"award-info":[{"award-number":["2021R1F1A1049320"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Optic neuritis (ON) detection is important for the early diagnosis and management of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). However, the conventional high-contrast visual evoked potential (VEP) used for ON detection lacks sensitivity for identifying ON presenting as mild or unremarkable visual disturbance, which is common in first-episode ON. Therefore, this study aimed to investigate whether a change in contrast or check size improves the sensitivity of VEP to first-ever ON. In total, 60 patients with the demyelinating disease (29 MS and 31 idiopathic patients with ON) without ON or with first-ever ON at least 6 months prior and 32 healthy controls underwent neuro-ophthalmic evaluations. VEPs were induced using three pattern-reversal checkerboard stimuli having, respectively, 10% contrast with a check size of 32' (LC32 VEP), 100% contrast with a check size of 32' (HC32 VEP; conventional VEP), and 100% contrast with a check size of 16' (HC16 VEP). The receiver operating characteristic (ROC) curve analysis and area under the curve (AUC) were calculated to determine the most appropriate VEP method for detecting optic nerve involvement. The optimal cut-off point was determined using the Youden index (J-index). The McNemar test was used to determine whether dichotomous proportions were equivalent. In comparison with first-ever ON eyes (<jats:italic>n<\/jats:italic> = 39) and healthy eyes (<jats:italic>n<\/jats:italic> = 64), LC32 VEP showed the highest AUC for discriminating ON (0.750, <jats:italic>p<\/jats:italic> &amp;lt; 0.001; 0.730 for HC32 VEP, <jats:italic>p<\/jats:italic> &amp;lt; 0.001; 0.702 for HC16 VEP, <jats:italic>p<\/jats:italic> = 0.001). In the first-ever ON group, LC32 VEP and conventional HC32 VEP were abnormal in 76.9 and 43.6%, respectively (McNemar, <jats:italic>p<\/jats:italic> &amp;lt; 0.001), and combining these tests did not improve sensitivity. These indicate that LC32 VEP is the most sensitive method for detecting first-ever ON. Visual evoked potential with 10% contrast stimuli was superior to conventional VEP for detecting first-ever ON. Thus, adding these LC stimuli might be helpful in identifying optic nerve involvement in ON with mild or unremarkable visual impairment.<\/jats:p>","DOI":"10.3389\/fneur.2022.804395","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T05:52:26Z","timestamp":1651211546000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Low Contrast Visual Evoked Potentials for Early Detection of Optic Neuritis"],"prefix":"10.3389","volume":"13","author":[{"given":"Soo-Hyun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choul-Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Sook","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1212\/WNL.0b013e3181dbb664","article-title":"Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity","volume":"74","author":"Balcer","year":"2010","journal-title":"Neurology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/jnnp-2016-313300","article-title":"Neurodegeneration in multiple sclerosis and neuromyelitis optica","volume":"88","author":"Kawachi","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","article-title":"MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines","volume":"15","author":"Filippi","year":"2016","journal-title":"Lancet Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/bjo.2010.193581","article-title":"Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis","volume":"96","author":"Bock","year":"2012","journal-title":"Br J Ophthalmol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1212\/CON.0000000000000768","article-title":"Optic neuritis","volume":"25","author":"Bennett","year":"2019","journal-title":"Continuum."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1167\/iovs.03-1213","article-title":"Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity","volume":"46","author":"Sisto","year":"2005","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cnp.2019.03.002","article-title":"The electrophysiological assessment of visual function in Multiple Sclerosis","volume":"8","author":"Barton","year":"2019","journal-title":"Clin Neurophysiol Pract."},{"key":"B10","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1177\/1352458517690822","article-title":"Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis","volume":"23","author":"Balcer","year":"2017","journal-title":"Mult Scler."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e733","DOI":"10.1212\/WNL.0000000000009832","article-title":"Optical coherence tomography for detection of asymptomatic optic nerve lesions in clinically isolated syndrome","volume":"95","author":"Outteryck","year":"2020","journal-title":"Neurology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3389\/fneur.2019.01076","article-title":"Retinal degeneration after first-ever optic neuritis helps differentiate multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"10","author":"Kim","year":"2019","journal-title":"Front Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1212\/wnl.33.8.1015","article-title":"The 20\/20 eye in multiple sclerosis","volume":"33","author":"Kupersmith","year":"1983","journal-title":"Neurology."},{"key":"B14","first-page":"1017","article-title":"The National Eye Institute visual function questionnaire: experience of the ONTT","volume":"41","author":"Cole","year":"2000","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jnnp.59.2.152","article-title":"Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria","volume":"59","author":"Beer","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1126","DOI":"10.1212\/NXI.0000000000001126","article-title":"Leveraging visual outcome measures to advance therapy development in neuroimmunologic disorders","volume":"9","author":"Graves","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0022-510x(86)90075-4","article-title":"Visual evoked responses and ophthalmological examination in optic neuritis: a follow-up study","volume":"75","author":"Hely","year":"1986","journal-title":"J Neurol Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/brain\/104.2.333","article-title":"Contrast sensitivity, visual acuity and the discrimination of Snellen letters in multiple sclerosis","volume":"104","author":"Regan","year":"1981","journal-title":"Brain."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1212\/WNL.0b013e3181c3fd43","article-title":"Evaluation of optic neuropathy in multiple sclerosis using low-contrast visual evoked potentials","volume":"73","author":"Thurtell","year":"2009","journal-title":"Neurology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ana.25462","article-title":"Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: an international study","volume":"85","author":"Nolan-Kenney","year":"2019","journal-title":"Ann Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1212\/WNL.0b013e3182661edc","article-title":"Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS","volume":"79","author":"Frohman","year":"2012","journal-title":"Neurology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jns.2019.02.015","article-title":"Low-contrast visual evoked potential and early detection of optic demyelination","volume":"399","author":"Luo","year":"2019","journal-title":"J Neurol Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"602193","DOI":"10.3389\/fneur.2020.602193","article-title":"Low contrast visual acuity might help to detect previous optic neuritis","volume":"11","author":"Park","year":"2020","journal-title":"Front Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis:2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/00055735-200212000-00006","article-title":"Acute demyelinating optic neuritis","volume":"13","author":"Foroozan","year":"2002","journal-title":"Curr Opin Ophthalmol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2174\/1874364101206010065","article-title":"Optic neuritis","volume":"5","author":"Dooley","year":"2010","journal-title":"J Ophthalmic Vis Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1177\/1352458517734070","article-title":"A population-based prospective study of optic neuritis","volume":"23","author":"Soelberg","year":"2017","journal-title":"Mult Scler."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-016-9553-y","article-title":"ISCEV standard for clinical visual evoked potentials: (2016 update)","volume":"133","author":"Odom","year":"2016","journal-title":"Doc Ophthalmol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/bimj.200710415","article-title":"Youden index and optimal cut-point estimated from observations affected by a lower limit of detection","volume":"50","author":"Ruopp","year":"2008","journal-title":"Biom J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1741-7015-4-7","article-title":"Revision of visual impairment definitions in the International Statistical Classification of Diseases","volume":"4","author":"Dandona","year":"2006","journal-title":"BMC Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/brain\/awu335","article-title":"Vision and vision-related outcome measures in multiple sclerosis","volume":"138","author":"Balcer","year":"2015","journal-title":"Brain."},{"key":"B32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00417-014-2590-x","article-title":"Evaluation of contrast sensitivity measurements after retrobulbar optic neuritis in Multiple Sclerosis","volume":"252","author":"Owidzka","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e66151","DOI":"10.1371\/journal.pone.0066151\/","article-title":"Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis","volume":"8","author":"Schneider","year":"2013","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3988\/jcn.2018.14.2.200","article-title":"Optical coherence tomography versus visual evoked potentials for detecting visual pathway abnormalities in patients with neuromyelitis optica spectrum disorder","volume":"14","author":"Kim","year":"2018","journal-title":"J Clin Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/eye.2011.81","article-title":"Optic neuritis","volume":"25","author":"Pau","year":"2011","journal-title":"Eye."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMcp053247","article-title":"Clinical practice. Optic neuritis","volume":"354","author":"Balcer","year":"2006","journal-title":"N Engl J Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1167\/iovs.11-7434","article-title":"Latency delay of visual evoked potential is a real measurement of demyelination in a rat model of optic neuritis","volume":"52","author":"You","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1212\/WNL.0b013e3181aaea32","article-title":"Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis","volume":"73","author":"Naismith","year":"2009","journal-title":"Neurology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.3389\/fnins.2021.692599","article-title":"Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?","volume":"20","author":"Di Maggio","year":"2014","journal-title":"Mult Scler."},{"key":"B41","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1177\/1352458513503053","article-title":"Visual evoked potentials in neuromyelitis optica and its spectrum disorders","volume":"20","author":"Ringelstein","year":"2014","journal-title":"Mult Scler."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1212\/01.wnl.0000094315.19931.90","article-title":"Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite","volume":"61","author":"Balcer","year":"2003","journal-title":"Neurology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/vision1010007","article-title":"The development and aging of the magnocellular and parvocellular visual pathways as indicated by VEP recordings between 5 and 84 years of age","volume":"1","author":"Benedek","year":"2016","journal-title":"Vision."},{"key":"B44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/schbul\/sbq114","article-title":"On identifying magnocellular and parvocellular responses on the basis of contrast-response functions","volume":"37","author":"Skottun","year":"2011","journal-title":"Schizophr Bull."},{"key":"B45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF00868339","article-title":"Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis","volume":"241","author":"Filippini","year":"1994","journal-title":"J Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.visres.2008.09.032","article-title":"Visual evoked spread spectrum analysis (VESPA) responses to stimuli biased towards magnocellular and parvocellular pathways","volume":"49","author":"Lalor","year":"2009","journal-title":"Vision Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.clinph.2005.06.013","article-title":"Impairments in generation of early-stage transient visual evoked potentials to magno- and parvocellular-selective stimuli in schizophrenia","volume":"116","author":"Schechter","year":"2005","journal-title":"Clin Neurophysiol."},{"key":"B48","first-page":"31","volume-title":"Evoked Potential in Clinical Medicine","author":"Chiappa","year":"1997"},{"key":"B49","first-page":"59","volume-title":"Sphehlmann's Evoked Potential Primer","author":"Misulis","year":"2001"},{"key":"B50","first-page":"506","article-title":"Simultaneous pattern reversal ERG and VER recordings. Effect of stimulus field and central scotoma","volume":"31","author":"Sakaue","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e407","DOI":"10.1212\/WNL.0000000000008684","article-title":"Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders","volume":"94","author":"Ringelstein","year":"2020","journal-title":"Neurology."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1066","DOI":"10.1212\/NXI.0000000000001066","article-title":"Remyelination trials: are we expecting the unexpected?","volume":"8","author":"Klistorner","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.804395\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T05:52:31Z","timestamp":1651211551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.804395\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":52,"alternative-id":["10.3389\/fneur.2022.804395"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.804395","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"article-number":"804395"}}